Proteomic approaches for studying human parenchymal lung diseases

Area of Science:

• Pulmonology
• Proteomics
• Biomarker Discovery

Background:

• Parenchymal lung diseases encompass diverse conditions with varied causes and outcomes.
• Chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF) are leading causes of lung morbidity and mortality.
• Both COPD and IPF are frequently diagnosed late and show limited response to current treatments.

Purpose of the Study:

• To provide an overview of chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis.
• To highlight distinct features of lung damage in these diseases and their reflection in various biological samples.
• To discuss challenges and advancements in nonbiased proteomic approaches for biomarker identification.

Main Methods:

• Review and synthesis of current literature on parenchymal lung diseases, focusing on COPD and IPF.
• Analysis of typical pathological features and sample types associated with each disease.
• Exploration of proteomic strategies for biomarker development.

Main Results:

• COPD is characterized by airway obstruction and emphysema, linked to smoking.
• IPF involves progressive lung fibrosis of unknown origin.
• Existing biomarkers for these conditions lack clinical validation.

Conclusions:

• Understanding disease-specific lung damage is crucial for diagnostic and therapeutic advancements.
• Nonbiased proteomic approaches hold promise for identifying novel biomarkers in parenchymal lung diseases.
• Further research is needed to validate proteomic findings for clinical application.